Improving risk evaluation and outcomes in childhood leukaemia [ 2014 - ]

Research Grant

Researchers: A/Pr Rosemary Sutton (Principal investigator) ,  A/Pr Tamas Revesz ,  Dr Luciano Dalla-Pozza ,  Draga Barbaric

Brief description The main objective of this project is to make substantial improvements in the treatment of patients with childhood leukaemia by greater use of molecular diagnostics to measure minimal residual disease (MRD) and high risk genetic changes in Australian patients enrolled on an international clinical trial which has been designed to reduce the incidence of both relapses and long term side-effects.

Funding Amount $771,596.00

Funding Scheme Project Grants

Notes Standard Project Grant